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Abstract
Background: Vitamin D, a hormone once thought to have a role limited to calcium homeostasis and bone
mineralization, has pleiotropic effects on different types of cells. Vitamin D receptors are reported in vascular
smooth muscle cells, endothelial cells, and cardiomyocytes. Adipose-derived MSCs (ADMSCs) are multipotent cells
with the capacity to differentiate into cells of different lineages. To our knowledge, the presence of vitamin D
machinery on porcine ADMSCs has not yet been examined. In this study, we investigated the presence of vitamin
D machinery and metabolism in ADMSCs by analyzing the expression levels of vitamin D receptor (VDR), vitamin D
metabolizing enzymes (CYP24A1 and CYP27B1) after in vitro stimulation with active vitamin D, calcitriol.
Methods and results: ADMSCs isolated from porcine adipose tissue were characterized by positive staining for
ADMSC markers, CD44, CD73, and CD90, and negative staining for macrophage marker CD11b and hematopoietic
stem cell markers CD34 and CD45, and trilineage differentiation to osteocytes, chondrocytes, and adipocytes.
No cytotoxicity was observed when MSCs were stimulated with 0.1–10 nM calcitriol. The ADMSCs were analyzed for
mRNA and protein expression of CYP24A1, CYP27B1, and VDR by immunostaining, qPCR, and ELISA. A significant
increase (p <0.01) in the mRNA expression of CYP24A1, CYP27B1, and VDR was observed after stimulation of ADMSCs
with calcitriol (10 nM). The in vitro time-dependent effect of calcitriol (10 nM) on the components of vitamin D
machinery in cultured MSCs was determined by qPCR. The VDR and CYP27B1 expression peaked at 3 h and CYP24A1
at 24 h, respectively. The in vitro biosynthesis of 1, 25(OH)2D3 by ADMSCs was analyzed by ELISA and Western blot.
The levels of the active form of vitamin D were significantly decreased once the CYP enzymes were inhibited (p <0.01),
demonstrating the ability of ADMSCs to convert inactive vitamin D into active vitamin D for cellular action.
Conclusions: Porcine ADMSCs possess vitamin D hydrolases and VDR to metabolize and respond to vitamin D. Hence,
in vivo circulating 25-hydroxy vitamin D levels may have a significant role in regulating the differentiation of ADMSCs
into different lineages, which might assist in stem cell-based therapy.
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Background
The clinical and biological importance of the steroid
hormone, vitamin D, has been extensively studied and
linked with multiple classical functions, notably in the
skeletal system, where it is responsible for calcium
absorption that leads to bone formation [1, 2]. Vitamin
D has been characterized as a fat-soluble steroid molecule
with one ring open that regulates various downstream
signaling pathways to control the transcription of many
target genes [3–5]. The deficiency in vitamin D has re-
cently been reported to be associated with non-skeletal
muscles illnesses, such as cancer, autoimmune diseases,
and cardiovascular disease [6–8]. Currently, the human
body can obtain vitamin D from two major sources:
dietary intake or by converting 7-dehydrocholesterol in
the skin when exposed to ultraviolet B light [9]. In the
body, vitamin D binds to vitamin D-binding protein and is
transported to the liver, where cholecalciferol is hydro-
xylated by the enzyme 25-hydroxylase into calcifediol (25-
hydroxyvitamin D3; 25(OH)D3). The 25(OH)D3 is then
hydroxylated in the kidney by 1α-hydroxylase (CYP27B1)
into the active form 1,25(OH)2D3 (calcitriol). In order to
remove any unused 1, 25(OH)2D3, the 24-hydroxylase
(CYP24A1), catabolizes 1, 25(OH)2D3 into biologically
inactive, water-soluble calcitroic acid and excreted from
the body [10, 11].
Recent studies have focused on cellular aspects of vita-
min D and have demonstrated expression of vitamin D
receptor (VDR) and vitamin D hydroxylases in many
other cell types such as vascular smooth muscle cells,
endothelial cells, and cardiomyocytes [12–14]. However,
little is known about how vitamin D may affect mesen-
chymal stem cells (MSCs). MSCs are multipotent cells
that have the capacity to self-renew and differentiate into
different lineages [15, 16]. Currently, most research is fo-
cused on obtaining MSCs from bone marrow. However,
the MSC population only constitutes 0.001–0.01 % of
the cell population in bone marrow, about tenfold less
than that of hematopoietic stem cells, which makes their
availability low in acute clinical conditions [17]. Consid-
ering the low availability of MSCs found in the bone
marrow, adipose tissue is a promising alternative, due to
its abundance in most individuals and that it can be
harvested using a simple liposuction procedure. This
procedure is less invasive and causes less discomfort and
damage to the site of trauma. Adipose tissue has a
significantly higher stem cell density than does bone
marrow, about 5 % versus 0.01 % of adipose-derived
mesenchymal stem cells (ADMSCs) suggesting that a
small amount of adipose tissue can yield sufficient stem
cells with proliferation and differentiation potential for
autologous cell transplantation, especially in acute
clinical settings [18]. Further increasing our knowledge
on how vitamin D interacts with ADMSCs can provide
us with information of how vitamin D can either alter or
maintain the same expression of certain receptors in a
cell, which in turn either classifies it as a differentiated
cell or allow the ADMSCs to keep the stem-like proper-
ties for a longer period. To our knowledge, the presence
of vitamin D machinery in porcine adipose-derived
MSCs has not yet been examined. Pigs are an ideal
model due to their cardiovascular and metabolic systems
being highly similar to humans in regard to the anatomy,
physiology, pharmacology, and pathophysiology. Our
laboratory has reported similar findings in human and
porcine models [19, 20]. Furthermore, the investigation
of MSCs from pigs is a direct translational option since
it has been reported that human and porcine MSCs have
comparable characteristics and functionality [21]. In this
study, we investigated the presence of vitamin D
machinery in adipose-derived MSCs by analyzing the
expression levels of vitamin D receptor (VDR) and vita-
min D metabolizing enzymes (CYP24A1 and CYP27B1)
after in vitro stimulation with active vitamin D, calcitriol.
Methods
Isolation and culture of porcine ADMSCs
DMSCs were isolated from porcine adipose tissue as
previously reported [22]. The Institutional Animal Care
and Use Committee approved the research protocol.
Briefly, porcine adipose tissue from the anterior abdom-
inal wall of pigs within the ages of 5 ½–6 ½ was
collected and transferred to the laboratory from the
slaughterhouse under sterile conditions. The ADMSCs
from abdominal fat have higher capacity to differentiate
into both adipogenic and osteogenic lineages than those
adipose tissues obtained from other areas, as reported in
the literature [23]. In addition, the proliferation rate was
also greater in the abdominal adipose tissue compared
to others [24]. The tissue was transported in Dulbecco’s
modified Eagle’s medium (DMEM) (Millipore Sigma, St.
Louis, MO, USA) with the following antibiotics: 100 mg/
mL penicillin (Millipore Sigma, St. Louis, MO, USA)
and 100 mg/mL streptomycin (Millipore Sigma, St.
Louis, MO, USA). About 10 grams of pig adipose tissue
was minced into 2–4 mm pieces with sterile scissors and
digested with 15 mL 0.2 % type 1 collagenase (Millipore
Sigma, St. Louis, MO, USA) for 2 h at 37 °C. Adding
serum-containing media then stopped the collagenase
activity. The floating cells were separated from the
vascular stromal fraction by centrifugation at 400 g for
10 min. The pellet (stromal vascular fraction) was then
filtered through a 100-μm nylon mesh to remove any
undigested tissue. The cells were then centrifuged in a
1.077 g/mL Histopaque (Millipore Sigma, St. Louis, MO,
USA) density gradient at 400 g for 30 min. The enriched
cells were collected from the interphase, washed twice with
serum-free medium and then resuspended in complete
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DMEM containing 10 % fetal bovine serum (FBS) (Gibco,
Thermo Fisher Scientific, Waltham, MA, USA), 100 mg/
mL penicillin (Millipore Sigma, St. Louis, MO, USA) and
100 mg/mL streptomycin (Millipore Sigma, St. Louis, MO,
USA). The cells were then cultured in a 25-cm2 flask at 37 °
C with 5 % CO2/95 % air and 90 % relative humidity. The
medium was changed every 2 days. Non-adherent
hematopoietic cells were removed by medium change every
24 h for 3 days. Afterward, the culture medium was
changed three times per week. Once adherent ADMSCs
became confluent, they were then trypsinized using 0.25 %
Trypsin–EDTA (Millipore Sigma, St. Louis, MO, USA),
and transferred to fresh 25-cm2 culture flasks. All experi-
ments were performed using MSCs at 3–6 passages.
Characterization of ADMSCs
Flow cytometric analysis was performed for the identifica-
tion of macrophage marker (CD11b), hematopoietic stem
cell markers (CD34 and CD45), and ADMSC markers
(CD44 and CD90). Cells (1 × 106/mL) were washed with
phosphate-buffered saline (PBS) that contained 4 % FBS
and were then incubated with the monoclonal antibodies,
antihuman CD11b-APC (Clone: ICRF44; eBiosciences,
San Diego, CA, USA), antihuman CD34-FITC (Clone:
581; BD Pharmingen, Franklin Lakes, NJ, USA), antihu-
man CD45-FITC (Clone: 2D1; eBiosciences, San Diego,
CA, USA), antihuman CD44-FITC (Clone: IM7; eBios-
ciences, San Diego, CA, USA) and antihuman CD90-PE
(Clone: 5E10; eBiosciences, San Diego, CA, USA) for
30 min at 4 °C in the dark. The dilution and concentration
of antibodies were used as specified by the manufacturers.
The cells were further washed three times with PBS and
resuspended in 500 μl PBS and flow cytometry was
performed on a FACS Aria Flow Cytometry System (BD
Biosciences, San Jose, CA, USA). FITC, APC and PE-
labeled IgGs (BD Pharmingen, Franklin Lakes, NJ, USA)
were used as the isotype control as well as positive beads
and negative beads [25].
To further observe the presence of surface markers,
immunofluorescence staining for CD11b, CD34, CD45,
CD73, CD90, and CD105 was performed and observed
by fluorescent microscopy. ADMSCs in passage four
were seeded in four chamber slides and allowed to reach
60 % confluency. Cells were then fixed with 3.7 %
formaldehyde in PBS for 10 min. The fixed monolayer
was then rinsed with PBS three times and permeabilized
by incubating with 0.1 % Triton-X 100 in PBS for
10 min. After PBS wash, the cells were blocked in 1 % bo-
vine serum albumin (BSA) in PBS for 1 hour and were fur-
ther incubated with CD11b, CD34, CD45, CD73, CD90,
and CD105 antibody (1:100 dilution) for 1 h at room
temperature. The cells were then further washed with PBS
and incubated with fluorescent-tagged secondary antibody
for 30 min. Following this the cells were washed with PBS
and mounted in Vectashield with DAPI (Millipore Sigma,
St. Louis, MO, USA) and observed using an upright
fluorescent microscope. Negative controls were run in
parallel in each analysis.
Trilineage differentiation of ADMSCs shows that
ADMSCs are capable of differentiating into respective
lineages. The ADMSCs were stimulated using STEM-
PRO osteogenesis, adipogenesis, and chondrogenesis
differentiation media using a kit for osteocyte, chondro-
cyte and adipocyte differentiation (Gibco, Thermo Fisher
Scientific, Waltham, MA, USA). For the three lineages,
the cells were cultured on chamber slides and the differ-
entiation medium was added at 80 % confluency. The
cells were then analyzed for osteogenesis by staining for
calcific deposition in the cells using Alizarin S Red after
14 days; adipogenic differentiation by staining for neutral
triglycerides and lipids with Oil O Red after 21 days; and
chondrogenesis by staining for the synthesis of proteo-
glycans for 21 days using Alcian blue. Following staining,
cells were observed under a bright field microscope. All
the histochemical reagents were obtained from Millipore
Sigma (St. Louis, MO, USA).
Analysis of vitamin D machinery
The cytotoxicity of calcitriol on ADMSCs was deter-
mined using a Vybrant Cytotoxicity Assay Kit (Molecu-
lar Probes, Eugene, OR, USA). The cells were plated in a
96-well microplate with the density of 500 and 1000
cells/well in a 50 μl volume. Cells were then stimulated
with different concentrations of calcitriol (0.1–100nM)
obtained from Millipore Sigma (St. Louis, MO, USA) for
24 h and 48 h. The Vybrant Cytotoxicity Assay Kit was
used to monitor the release of cytosolic enzyme glucose-
6-phosphate dehydrogenase (G6PD) from damaged cells
into the surrounding medium. It was then quantitatively
determined according to the manufacturer’s instructions
by measuring the absorbance at 450 nm.
Total RNA was isolated from treated ADMC with Tri-
zol reagent (Millipore Sigma, St. Louis, MO, USA) after
treating the cells with 10 nM of calcitriol for 0, 3, 6, 12,
and 24 h (n = 3/group) [26]. The yield of RNA was quan-
tified using a NanoDrop (Thermo Fisher Scientific, Wal-
tham, MA, USA). First-strand cDNA synthesis was
performed using 1 μg total RNA with oligo(dT) (1 μg),
5 × reaction buffer, MgCl2, dNTP mix, RNAse inhibitor
and Improm-II reverse transcriptase as per instructed by
the kit (Promega, Madison, WI, USA). Following the
first-strand synthesis, real-time PCR analysis was per-
formed for the identification of CYP27B1, CYP24A1,
VDR, using 8 μl cDNA, 10 μl SYBR green PCR Master
Mix (Bio-Rad Laboratories, Hercules, CA, USA) and for-
ward and reverse primers (10 pmol/μl) (Integrated DNA
Technologies, San Diego, CA, USA) using a Real-Time
PCR system (CFX96, Bio-Rad Laboratories, Hercules,
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CA, USA). The specificity of the primers was analyzed
by running a melting curve. The PCR cycling condi-
tions were 5 min at 95 °C for initial denaturation,
40 cycles of 30 s at 95 °C, 30 s at 52–58 °C (dep-
ending upon the primer annealing temperatures) and
30 sec at 72 °C. Each real-time PCR was carried out
using three individual samples in duplicates and the
threshold cycle values were averaged. Calculations of
relative normalized gene expression were performed
using the Bio-Rad CFX manager software based on
the ΔΔCt method. The results were normalized against
housekeeping gene: glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH). Statistical analysis of real-time
quantitative PCR results was performed using a one-
way ANOVA test.
Immunofluorescent staining for CYP24A1, CYP27B1,
and VDR was performed. The treated cells were fixed with
3.7 % formaldehyde in PBS for 10 min. The fixed mono-
layer of the cells were rinsed with PBS and permeabilized
with 0.1 % Triton-X 100 in PBS for 10 min. After PBS wash,
the cells were blocked in 1 % BSA in PBS for 1 h and were
further incubated with CYP27B1, CYP24A1, and VDR
antibodies (1:100 dilution; Santa Cruz Biotechnology, Dal-
las, TX, USA) for 1 h at RT. The cells were then further
washed with PBS and incubated with fluorescent-tagged
secondary antibody for 30 min. Finally, the cells were
again washed with PBS then mounted in Vectashield
with DAPI (Vector Laboratories, Burlingame, CA,
USA) and visualized using an upright fluorescent
microscope (Olympus BX51, St. Louis, MO, USA).
Negative controls were employed in each analysis by
omitting calcitriol as a treatment.
Cytochrome P450 24A1 (CYP24A1), and Cytochrome
P450 27B1 (CYP27B1) ELISA kits (MyBioSource, San
Diego, CA, USA) were used to quantify CYP24A1 and
CYP27B1 levels after stimulation of ADMSCs with calci-
triol at 0, 3, 6, 12, and 24 h. ADMSCs were detached
using trypsin and then collected by centrifugation. The
cells were then washed three times with cold PBS before
resuspension in PBS. The cells were then lysed through
ultrasonication. Next, they were centrifuged at 1500 g
for 10 min at 2–8 °C to remove cellular debris. The cells
were then added to 96-well plates and assessed
according to the manufacturer’s instructions with the
absorbance measured at 450 nm on a plate reader.
MSCs were cultivated in 25-cm2 culture flasks until
80 % confluence. Cells were then treated with or without
1 nM calcifediol (25(OH)D3), with or without 1 μM CYP
inhibitor ketoconazole in serum-free medium. After 24 h
treatment, the media was collected from each well. The
1,25(OH)2D3 levels in the media were quantitatively
determined with a 1,25(OH)2D3 ELISA kit (My-




The plastic adherent cells showed fibroblastoid morphology
and stained positively for CD44, CD73 (5′-nucleotidase),
CD90 (Thy-1), and CD105 (Endoglin). Contamination with
other cells was ruled out by negative reactivity to CD11b
(macrophage marker), CD34, and CD45 (hematopoietic
stem cell markers) (Fig. 1A). The results were further
confirmed with immunophenotyping with flow cytometric
analysis. The cells expressed CD44 and CD90, further in-
dicating that the cells originate from a mesenchymal lineage
(Figs. 1Bd-e). The frequent change of medium after seeding
was effective in preventing the attachment of hematopoietic
stem cells and other non-adherent cells, and thus the
absence of CD11b+, CD34+ and CD45+ in the population
of ADMSCs.
Cells stained with Alizarin S Red for 14 days showed
positive staining for osteogenesis (Fig. 2a). The adipogenic
and chondrogenic differentiation of the cells was con-
firmed by the staining for 21 days with Oil O Red (Fig. 2b)
and Alcian blue (Fig. 2c), respectively. The cells were
observed under a bright field microscope after staining.
The immunophenotyping coupled with trilineage differen-
tiation demonstrated mesenchymal multipotency and
effectively confirmed isolated cells to be ADMSCs.
Analysis of vitamin D machinery
The cytotoxicity assay was performed to examine the
dose of calcitriol that induce cytotoxicity in ADMSCs.
Calcitriol induced a dose-dependent effect when the
ADMSCs were stimulated with a concentration that
ranged from 0.1–100 nM (Fig. 3) during 24 hours
(Fig. 3a) and 48 hours (Fig. 3b). A large amount of
cytosolic enzyme, G6PD, was released from the cells stim-
ulated with 100 nM calcitriol (Fig. 3a and b) compared to
the cells stimulated with 0–50 nM calcitriol (Fig. 3a and
b); there was a difference in the release of G6PD at 0–50
nM calcitriol. Since calcitriol induced cytotoxicity at 100
nM and also the circulating amount of calcitriol in the
human body ranges from 0.1 to 10 nM, a dose of 10 nM
calcitriol was selected in later experiments.
Real-time PCR revealed the expression of the vitamin D
machinery genes VDR, CYP24A1, and CYP27B1 (Fig. 4a-
c), after stimulation with calcitriol (10 nM) for 0, 3, 6, 12,
and 24 h, respectively. There was a significant change in
the VDR expression when cells were treated at 3, 6, and
12 h, showing the largest increase at 3–6 h (p = 0.0001)
followed by a drop at 24 h (Fig. 4a). However, there was
time-dependent increase in CYP24A1 with the greatest
expression occurring at 24 h (Fig. 4b). In parallel, expres-
sion of CYP27B1 significantly decreased with calcitriol
treatment (Fig. 4c). The findings confirmed the effect of
calcitriol on mRNA expression of vitamin D machinery
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genes. The expressions of these markers were consistent
at least throughout the 2nd to 8th passages of ADMSCs.
After 24 h stimulation with calcitriol, immunofluores-
cence demonstrated the presence of VDR, CYP24A1, and
CYP27B1 proteins (Fig. 5A). Translation of CYP24A1 and
CYP27B1 mRNA into proteins at 0, 3, 6, 12, and 24 h was
demonstrated using an ELISA kit (MyBioSource, San
Diego, CA, USA). These results correlated with the mRNA
data. There was a significant increase in CYP24A1 over 0
to 24 h (Fig. 5Aa, p < 0.0001), with the greatest protein
expression at 24 h. Furthermore, the expression of
CYP27B1 (Fig. 5Bb) correlated with the mRNA data except
that the drop in mRNA occurred at 3 h (Fig. 4c), whereas
the drop in the protein levels occurred at 6 h (Fig. 5Bb).
Fig. 2 Trilineage-differentiating capability of ADMSCs. The isolated ADMSCs were stimulated with specific differentiation media to examine their
trilineage differentiation: (a) Alizarin red staining showing the presence of calcium deposition by cells, demonstrating differentiation of ADMSCs to
osteogenic lineage, (b) Alcian blue staining indicating synthesis of proteoglycans by chondrocytes showing cell differentiation to chondrogenic
lineage, and (c) Oil Red O staining indicating the synthesis of neutral triglycerides and lipids, showing differentiation of ADMSCs to adipocytes
Fig. 1 Characterization of ADMSCs using surface markers. a Phase contrast image showing morphology of adipose-derived MSCs (a),
immunostaining data showing negative staining of macrophage marker CD11b (b) and hematopoietic stem cell marker CD34 (c) and
CD45 (d); and positive staining for CD44 (e), CD73 (f), CD90 (g), CD105 (h), which are the characteristics of ADMSCs. B Flow cytometry
data showing negative expression of CD11b (a), CD34 (b), CD45 (c) and positive expression of CD44 (d), and CD90 (e) in the cultured
cells. The black histogram represents the isotype control and stained cells are represented by the blue histogram (n = 3)
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There was no detectable level of 1,25(OH)2D3 in cell
culture without adding 1 nM 25(OH)D3 exogenously
(Fig. 6). The levels of the active form of vitamin D, 1,25
(OH)2D3, and CYP27B1 were significantly increased
(Fig. 6; p = 0.001) in the ADMSCs upon stimulation with
inactive form of vitamin D, 25(OH)D3. There was mild
but insignificant increase in the level of 1,25(OH)2D3 by
ketoconazole (1 μM) in the absence of 25(OH)D3. The
conversion of inactive vitamin D to active form was
almost abolished by 1 μM ketoconazole (Fig. 6).
Discussion
Mesenchymal stem cells offer a wide range of practical
use in regenerative medicine and are currently being
investigated for the treatment of diseases, inclu-
ding cardiac [27] and neurodegenerative diseases [28].
Fig. 3 Dose-dependent effect of calcitriol on cytotoxicity. The cytotoxic effect of calcitriol was examined by detecting dead and dying cells using
the Vybrant Cytotoxicity Assay Kit after stimulation of ADMSCs with varying concentrations of calcitriol. ADMSCs were treated with 0 nM, 0.1 nM,
1 nM, 10 nM, 50 nM, and 100 nM calcitriol for 24 h (a) and 48 h (b), respectively and further assayed for glucose 6-phosphate dehydrogenase
release. The fluorescence was measured using a microplate reader with excitation/emission at 530/590 nM
Fig. 4 Effect of calcitriol on mRNA transcripts for VDR, CYP24A1 and CYP27B1. Real-time PCR data showing fold change in the expression of VDR
(a), CYP24A1 (b) and CYP27B1 (c) after stimulation with calcitriol (10 nM) for 0 h, 3 h, 6 h, 12 h, and 24 h respectively (***p = 0.0001, **p < 0.01,
*p < 0.05, n = 3)
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ADMSCs are characterized by their adherence to plastic
as well as cell surface expression of CD44, CD73, CD90,
and CD105, while lacking CD11b+, CD34+, and CD45+.
The isolated cells showed strong signals for the group of
receptors that are classified as mesenchymal stem cells
versus another type of cell that could contaminate the cell
culture, such as macrophages, and fibroblasts [29]. How-
ever, differentiation into mesoderm derivatives, i.e., osteo-
cytes, chondrocytes, and adipocytes, confirms stem cell
classification of the isolated cells [17]. The ADMSCs were
also controlled for age-related problems, such as DNA
methylation and osteogenic differentiation, since it has
been reported that potentially age may alter the ADMSCs
[30, 31], by collecting ADMSCs from pigs 5½–6½months
of age, although we found no significant difference in the
phenotype of ADMSCs at least up to 24 months age of
the pigs. None-the-less, since we used the adipose tissues
from pigs of the same age we do not expect much
variance. Furthermore, others have reported that ADMSC
differentiation remains consistent with age compared to
bone marrow MSCs [32]. The isolation process of the
ADMSCs from the adipose tissue was thus standardized
and established in our laboratory for further experiments
on the function and differentiation of ADMSCs.
Strategies for differentiating ADMSCs into different
lineages have become a focus due to the therapeutic
Fig. 5 Effect of calcitriol on protein expression of VDR, CYP24A1, and CYP27B1. a Phase contrast image showing expressions of VDR (a), CYP24A1
(b) and CYP27B1 (c) after stimulation with calcitriol (10 nM) for 24 hours. b ELISA data showing fold change in the expression of CYP24A1 (a) and
CYP27B1 (b) after stimulation with calcitriol (10 nM) for 0 h, 3 h, 6 h, 12 h, and 24 h respectively (***p < 0.0001, n = 6)
Fig. 6 Effect of CYP inhibitor on the conversion of inactive to active vitamin D in ADMSCs. Baseline level of 1, 25(OH)2D3 in cell culture was
measured. ADMSCs were then stimulated with 1 nM 25(OH)D3 for 24 hours. Effect of the CYP inhibitor, 1 μM ketoconazole, was examined by
itself or in the presence of 1 nM 25(OH)D3. (
***p = 0.001; n = 3)
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possibilities. However, not much is known about the
effects of micronutrients, including vitamin D, on
ADMSCs. The importance of isolating ADMSCs from
adipose tissue is stressed due to their high density when
compared to the availability of ADMSCs isolated from
bone marrow. Adipose tissue is abundant in most indi-
viduals and can be harvested using a simple liposuction
procedure. This is less invasive and causes less discom-
fort and damage to the site of trauma. Adipose tissue
has a significantly higher stem cell density than in the
bone marrow, about a fivefold increase, suggesting that a
small amount of adipose tissue can yield sufficient stem
cells with proliferation and differentiation potential for
autologous cell transplantation, especially in acute
clinical settings [18].
Vitamin D deficiency results in low bone density, and in
severe cases, osteomalacia. It is also associated with osteo-
penia, osteoporosis, muscle weakness, and increased prob-
ability of bone fracture [33–35]. Vitamin D deficiency has
also been reported to be associated with non-skeletal
muscle illnesses, such as cancer, autoimmune diseases, in-
fectious disease, and cardiovascular disease [36]. There are
two known major sources of vitamin D. One is obtained
from dietary intake. The other is chemically synthesized in
the skin from 7-dehydrocholesterol. Vitamin D that is ob-
tained through either process goes through multiple steps
of action to form 1,25-dihydroxyvitamin D [1,25(OH)2D3]
[37]. This active form is taken up by target cells with the
vitamin D receptor (VDR). Vitamin D is primarily
activated by CYP27B1 found in the kidney tubule cells.
However, additional human cells have been shown to
produce [1,25(OH)2D3], such as vascular smooth muscle
cells, endothelial cells, and cardiomyocytes. Finding the
VDR and vitamin D hydroxylase in many other tissues
suggest that vitamin D hormone acts in an autocrine,
paracrine, or an intracrine way to affect the biology of
non-classical target tissues [38]. We have demonstrated
the presence of the vitamin D machinery; however, the
purpose of the machinery in ADMSCs is still not known.
In this study, ADMSC were treated with vitamin D
levels similar to those found in the human body. Higher
concentrations of 1,25(OH)2D3 (100 nM) induced cyto-
toxicity and necrosis. Thus, a 10 nM dose was selected for
this experiment due to its low cytotoxicity and its proxim-
ity to normal serum levels [39]. During treatment, VDR,
CYP24A1, and CYP27B1 are upregulated. The observed
increase in the expression of VDR, CYP24A1, and
CYP27B1 in response to calcitriol treatment is consistent
with the findings in the literature in other cells related to
vitamin D metabolism [40–42]. However, the most
intriguing and novel finding is that the stimulation of
ADMSCs with calcitriol significantly decreased the
CYP27B1 expression, while simultaneously increasing
CYP24A1 levels. Thus, treatment of ADMSCs with
calcitriol inhibits active vitamin D synthesis while also
promoting inactivation. This supports our hypothesis that
adipose-derived mesenchymal stem cells possess the
machinery to metabolize vitamin D. Also, the conversion
of cholecalciferol into calcitriol by ADMSCs is a novel
finding. This axis promotes cell differentiation or preserves
stem cell properties. Further investigation into the func-
tion of vitamin D regulation in ADMSCs is warranted and
could lead to better understanding of the differentiation
process of ADMSCs.
Conclusions
This is the first report to demonstrate that porcine
adipose-derived mesenchymal stem cells contain
vitamin D hydrolases and VDR and are able to convert
inactive vitamin D into active vitamin D and respond to
different concentrations of vitamin D. Hence, in vivo
circulating 25-hydroxy vitamin D may have a role in
regulating the differentiation of ADMSCs. Further
elucidation of ADMSC differentiation has wide clinical
potential. Considering their high density and easy isola-
tion, ADMSCs have implications in autologous trans-
plantation in clinical settings.
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